Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.37 BRL | +3.51% | +3.00% | -9.91% |
Mar. 04 | Barclays Downgrades Ambev to Equalweight From Overweight, Adjusts Price Target to $3 From $3.50 | MT |
Feb. 29 | Transcript : Ambev S.A., Q4 2023 Earnings Call, Feb 29, 2024 |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- The company is one of the best yield companies with high dividend expectations.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Brewers
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-9.91% | 38.43B | B- | ||
-4.96% | 119B | A- | ||
-1.70% | 55.05B | B+ | ||
+5.93% | 46.85B | C+ | ||
-2.81% | 22.69B | - | B+ | |
-22.44% | 19.14B | B | ||
+9.59% | 19.09B | B | ||
+3.25% | 17.99B | A- | ||
+8.63% | 15.43B | B- | ||
+11.16% | 12.92B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ABEV3 Stock
- Ratings Ambev S.A.